« previous next »
Pages: [1]

Author Topic: Abreos Biosciences launches lab test for precision dose monitoring of Tysabri  (Read 150 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
Abreos Biosciences launches lab test for precision dose monitoring of Tysabri
« on: August 22, 2018, 02:32:46 pm »

Abreos Biosciences has come out with a test for monitoring the levels of Tysabri in patients' systems for the purpose of getting a closer control of the PML risk:

https://www.prweb.com/releases/abreos_biosciences_launches_laboratory_developed_test_for_precision_dose_monitoring_of_natalizumab_tysabri/prweb15705476.htm
« Last Edit: August 29, 2018, 09:17:15 pm by agate »
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
283 Views 		Last post November 30, 2013, 08:04:56 pm
by agate
0 Replies
150 Views 		Last post October 21, 2017, 04:06:54 pm
by agate
0 Replies
53 Views 		Last post April 24, 2020, 10:04:52 pm
by agate
0 Replies
70 Views 		Last post August 09, 2020, 09:45:38 pm
by agate
0 Replies
38 Views 		Last post May 31, 2022, 09:02:38 pm
by agate